Table 6 Incidence of liver and renal lesion and thrombocytopenia in each group
Adverse reactions | Nadroparin group (n = 152) | Enoxaparin group (n = 113) | Dalteparin group (n = 45) | P value |
|---|---|---|---|---|
Liver lesion (n, %) | 16 (10.5%) | 9 (8.0%) | 3 (6.7%) | 0.68* |
Renal lesion (n, %) | 1 (0.66%) | 1 (0.88%) | 0 (0%) | NA |
HIT (n, %) | 0 (0%) | 0 (0%) | 0 (0%) | NA |
PLT count decrease > 30% | 15 (9.9%) | 7 (6.2%) | 5 (11.1%) | 0.48 |